LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) March 29, 2024 β 21:00
Cherry Blossom Season Exploration in Oshiage and Asakusa Area: TOKYO SKYTREE Special Discount Package March 26, 2024 β 10:30
Hancom announces strategic investment in Spanish AI biometric company FacePhi March 25, 2024 β 07:00
From Guangzhou to the World: Onuge Group showcase of Innovation and Quality at Cosmoprof Bologna 2024 March 23, 2024 β 16:11